What can be learned from the history of recurrence in migraine? A comment

Journal of Headache and Pain

Volumn 10, Issue 5, 2009, Pages 311-315

  Tfelt Hansen, Peer ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ergotamine; Recurrence; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; CAFERGOT; ELETRIPTAN; ERGOT ALKALOID; ERGOTAMINE; FROVATRIPTAN; METOCLOPRAMIDE; NAPROXEN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

AGE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DISABILITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TREATMENT FAILURE; HEADACHE; HUMAN; MIGRAINE; NAUSEA; NEUROPATHOLOGY; NONHUMAN; PHOTOPHOBIA; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SEDATION; SEX DIFFERENCE; SIDE EFFECT;

CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE DISORDERS; RECURRENCE; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 70349257161     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0144-0     Document Type: Review

References (45)

1. Visser WH, Burggraaf J, Muller LM, Schoemaker RC, Fowler PA, Cohen AF, Ferrari MD (1996) Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Clin Pharmacol Ther 60:452-460
2. Pilgrim AJ (1991) Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur J Neurol 31:295-299
3. Lipton RB, Hamelsky SW, Dayno JM (2002) What do patients with migraine want from acute migraine treatment? Headache 42(suppl 1):S3-S9
4. Lantéri-Minet M (2005) What do patients want from their acute migraine therapy? Eur Neurol 53(suppl 1):3-9
5. Gallagher R (2004) What do patients want from acute migraine treatment? Cephalalgia 24(suppl 2):8-15
6. Tfelt-Hansen P, Brand J, Dano P, Doenicke A, Findley LJ, Iversen HK et al (1989) Early clinical experience with subcutaneous GR43175 in acute migraine: An overview. Cephalalgia 9(suppl 9):73-77
7. International Headache Society Committee on Clinical Trials in Migraine (1991). Guidelines for controlled trials of drugs in migraine, 1st edn. Cephalalgia 11:1-12
8. International Headache Society Clinical Trial Subcommittee (2000). Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 20:765-786
9. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 358:1668-1675
10. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr (1991) Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265:2831-2835
11. The Oral Sumatriptan Dose-Defining Study Group (1991) Sumatriptan - an oral dose-defining study. Eur Neurol 31:300-305
12. Sullivan JT, Preston KL, Testa MP, Busch M, Jasinski DR (1992) Psychoactivity and abuse potential of sumatriptan. Clin Pharmacol Ther 52:635-642
13. The Oral Sumatriptan International Multiple-Dose Study Group (1991) Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 31:306-313
14. The Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with sumatriptan. N Eng J Med 325:316-321
15. Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259-1287
16. Saxena PR, Tfelt-Hansen P (2006) Triptans, 5HT1B/1D agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 469-503
17. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group (1992) A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 32:177-184
18. Multinational Oral Sumatriptan and Cafergot Coparative Study Group (1991) A randomized, double-blind comparison of sumatriptan in the acute treatment of migraine. Eur Neurol 31:314-322
19. Saxena PR, Tfelt-Hansen P (1993) Sumatriptan. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches. Ravens Press, New York, pp 329-341
20. Saxena PR, Tfelt-Hansen P (2000) Triptans, 5-HT 1B/1D receptor agonists, in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 411-438
21. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT 1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633-658
22. Rapoport A, Visser WH, Cutler NR, Alderton CJ, Paulsgrove LA, Davis RL et al (1995) Oral sumatriptan in preventing headache recurrence after treatment of migraine arracks with subcutaneous sumatriptan. Neurology 45:1505-1509
23. Ferrari MD, James MH, Bates D, Pilgrim A, Ashford E, Andersson BA (1994) Oral sumatriptan: Effect of a second dose, and treatment of headache recurrence. Cephalalgia 14:330-338
24. Scott RJ, Aitchison WRC, Barker PR, McLaren GI (1996) Oral treatment in the acute treatment of migraine and migraine and migraine recurrence in general practice. Q J Med 89:613-622
25. Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ et al (2007) Sumatriptan-naproxen for acute treatment of migraine. A randomized trial. JAMA 297:1443-1454
26. Visser WH, Jaspers NM, de Vriend RH, Ferrari MD (1996) Risk factors for headache recurrence after sumatriptan. A study in 366 migraine patients. Cephalalgia 16:264-269
27. Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener H-C, Almas M, Albert KS, Parsons B (2008) Predictor of migraine headache recurrence a pooled analysis from the eletriptan data base. Headache 48:184-193
28. Géraud G, Keywood C, Senard JM (2003) Migraine headache recurrence: Relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 43:376-388
29. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L (2005) Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled study. CNS Drugs 19:125-136
30. Spierings EL, Rapoport AM, Dodick DW, Charlesworth B (2004) Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 18:1133-1141
31. Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, Block GA, Reines SA, Visser WH on behalf of the Rizatriptan 030 study Group (1998) Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine. Headache 38:748-755
32. Tfelt-Hansen P (2008) Frovatriptan and data publication. Headache 48:1382-1383
33. Headache Classification Committee of the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain, 2nd edn. Cephalalgia 24(suppl 1):1-164
34. Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV et al (1995) Brainstem activation in spontaneous human migraine attacks. Nat Med 1:658-660
35. Afridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowick RS et al (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128:932-939
36. Diener HC, May A (1996) New aspects of migraine pathophysiology: Lessons learned from positron emission tomography. Curr Opin Neurol 9:199-201
37. Kelman L (2006) The postdrome of the acute migraine attack. Cephalalgia 26:214-220
38. Goadsby PJ, Dodick D, Almas M, Diener H-C, Tfelt-Hansen P, Lipton RB, Parsson B (2007) Treatment emergent CNS symptoms following triptan therapy are part of the migraine attack. Cephalalgia 27:254-262
39. Tfelt-Hansen P, Paalzow L (1985) Intramuscular ergotamine: Plasma levels and dynamic activity. Clin Pharmacol Ther 37:29-35
40. Østergaard JR, Mikkelsen E, Voldby B (1981) Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery. Cephalalgia 1:223-228
41. Tfelt-Hansen P, Østergaard JR, Göthgen I, Jacobsen E, Rasmussen JP, Husum B (1982) Nitroglycerin for ergotism-experimental studies in vitro and in migraine patients and treatment of an overt case. Eur J Clin Pharmacol 22:105-109
42. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR (1998) Coronary side effect potential of current and prospective antimigraine drugs. Circulation 98:25-30
43. Tfelt-Hansen P, Nilsson E, Edvinsson L (2007) Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat. J Headache Pain 8:83-89
44. Müller-Schweinitzer E (1984) What is known about the action of dihydroergotamine on the vasculature in man? Int J Clin Pharmacol Ther Toxicol 22:677-682
45. Müller-Schweinitzer E (1980) In vitro study on the duration of action of dihydroergotamine. Int J Clin Pharmacol Ther Toxicol 18:88-91